Abstract
Several psychiatric disorders, including juvenile Attention Deficit/Hyperactivity Disorder (ADHD), have been associated with abnormalities of certain long-chain PUFA (LCPUFA). Despite this reported association, the FA levels of patients with the adult form of ADHD have not previously been evaluated. In this study we measured the total blood phospholipid FA concentrations in 35 control subjects and 37 adults with ADHD symptoms to determine whether adults with ADHD symptoms would show abnormalities of FA relative to control subjects. In the serum phospholipids, adults with ADHD symptoms had significantly lower levels of total saturated, total polyunsaturated, and total omega-6 (n−6) FA, as well as the omega-3 (n−3) LCPUFA DHA (22∶6n−3), and significantly higher levels of total monounsaturated FA and the n−3 LCPUFA docosapentaenoic acid (22∶5n−3). In the erythrocyte membrane phospholipids, adults with ADHD symptoms had significantly lower levels of total PUFA, total n−3 FA, and DHA, and significantly higher levels of total saturated FA. Neither serum nor erythrocyte membrane phospholipid DHA was related to ADHD symptom severity (as assessed by the Amen questionnaire) in ADHD subjects. Although the exact cause of these variations is unknown, both environmental and genetic factors may be involved.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AA:
-
arachidonic acid
- ADHD:
-
Attention Deficit/Hyperactivity Disorder
- ALA:
-
α-linolenic acid
- DGLA:
-
dihomo-γ-linolenic acid
- DPA:
-
docosapentaenoic acid
- GLA:
-
γ-linolenic acid
- LA:
-
linoleic acid
- LCPUFA:
-
long-chain PUFA
- LNA:
-
linolenic acid
- n−3:
-
omega-3
- n−6:
-
omega-6
- PLA2:
-
phospholipase A2
- RBC:
-
red blood cell
References
Simopoulos, A.P. (1991) Omega-3 Fatty Acids in Health and Disease and in Growth and Development, Am. J. Clin. Nutr. 54, 438–463.
Sastry, P.S. (1985) Lipids of Nervous Tissue: Composition and Metabolism, Prog. Lipid Res. 24, 69–176.
Brenner, R.R. (1984) Effect of Unsaturated Fatty Acids on Membrane Structure and Enzyme Kinetics, Prog. Lipid Res. 23, 69–96.
Spector, A.A., and Yorek, M.A. (1985) Membrane Lipid Composition and Cellular Function, J. Lipid Res. 26, 1015–1035.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn., pp. 78–85, American Psychiatric Publishing, Arlington, VA.
Spencer, T., Biederman, J., Wilens, T.E., and Faraone, S.V. (1994) Is Attention Deficit Hyperactivity Disorder in Adults a Valid Disorder? Harv. Rev. Psychiatry 1, 326–335.
Pary, R., Lewis, S., Matuschka, P.R., and Lippmann, S. (2002) Attention-Deficit/Hyperactivity Disorder: An Update, South. Med. J. 95, 743–749.
Mitchell, E.A., Aman, M.G., Turbott, S.H., and Manku, M. (1987) Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children, Clin. Pediatr. 26, 406–411.
Stevens, L.J., Zentall, S.S., Deck, J.L., Abate, M.L., Watkins, B.A., Lipp, S.R., and Burgess, J.R. (1995) Essential Fatty Acid Metabolism in Boys with Attention-Deficit Hyperactivity Disorder, Am. J. Clin. Nutr. 62, 761–768.
Stevens, L.J., Zentall, S.S., Abate, M.L., Kuczek, T., and Burgess, J.R. (1996) Omega-3 Fatty Acids in Boys with Behavior, Learning, and Health Problems, Physiol. Behav. 59, 915–920.
Voigt, R.G., Llorente, A.M., Jensen, C.L., Fraley, J.K., Berretta, M.C., and Heird, W.C. (2001) A Randomized, Double-Blind, Placebo-Controlled Trial of Docosahexaenoic Acid Supplementation in Children with Attention-Deficit/Hyperactivity Disorder, J. Pediatr. 139, 189–196.
Edwards, R., Peet, M., Shay, J., and Horrobin, D. (1998) Omega-3 Polyunsaturated Fatty Acid Levels in the Diet and in Red Blood Cell Membranes of Depressed Patients, J. Affect. Disord. 48, 149–155.
Peet, M., Murphy, B., Shay, J., and Horrobin, D. (1998) Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients, Biol. Psychiatry 43, 315–319.
Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., and Meltzer, H. (1996) Fatty Acid Composition in Major Depression: Decreased ω3 Fractions in Cholesteryl Esters and Increased C20∶4ω6/C20∶5ω3 Ratio in Cholesteryl Esters and Phospholipids, J. Affect. Disord. 38, 35–46.
Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H., and Meltzer, H.Y. (1999) Lowered ω3 Polyunsaturated Fatty Acids in Serum Phospholipids and Cholesterol Esters of Depressed Patients, Psychiatry Res. 85, 275–291.
Puri, B.K., Richardson, A.J., Horrobin, D.F., Easton, T., Saeed, N., Oatridge, A., Hajnal, J.V., and Bydder, G.M. (2000) Eicosapentaenoic Acid Treatment in Schizophrenia Associated with Symptom Remission, Normalization of Blood Fatty Acids, Reduced Neuronal Membrane Phospholipid Turnover and Structural Brain Changes, Int. J. Clin. Pract. 54, 57–63.
Puri, B.K., and Stiner, R. (1998) Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment with Eicosapentaenoic Acid, Arch. Gen. Psychiatry 55, 188–189.
Assies, J., Lieverse, R., Vreken, P., Wanders, R.J., Dingemans, P.M., and Linszen, D.H. (2001) Significantly Reduced Docosahexaenoic and Docosapentaenoic Acid Concentrations in Erythrocyte Membranes from Schizophrenic Patients Compared with a Carefully Matched Control Group, Biol. Psychiatry 49, 510–522.
Hibbeln, J.R., Linnoila, M., Umhau, J.C., Rawlings, R., George, D.T., and Salem, N. (1998) Essential Fatty Acids Predict Metabolites of Serotonin and Dopamine in Cerebrospinal Fluid among Healthy Control Subjects, and Early- and Late-Onset Alcoholics, Biol. Psychiatry 44, 235–242.
Stoll, A.L., Severus, W.E., Freeman, M.P., Rueter, S., Zboyan, H.A., Diamond, E., Cress, K.K., and Marangell, L.B. (1999) Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-Blind, Placebo-Controlled Trial, Arch. Gen. Psychiatry. 56, 407–412.
Soderberg, M., Edlund, C., Kristensson, K., and Daliner, G. (1991) Fatty Acid Composition of Brain Phospholipids in Aging and Alzheimer's Disease, Lipids 26, 421–425.
Guan, Z.Z., Soderberg, M., Sindelar, P., and Edlund, C. (1994) Content and Fatty Acid Composition of Cardiolipin in the Brain of Patients with Alzheimer's Disease, Neurochem. Int. 25, 295–300.
Kyle, D.J., Schaefer, E., Patton, G., and Beiser, A. (1999) Low Serum Docosahexaenoic Acid Is a Significant Risk Factor for Alzheimer's Dementia, Lipids 34, S245.
Tilvis, R.S., Erkinjunti, T., Sulkava, R., and Miettinen, T.A. (1987) Fatty Acids of Plasma Lipids, Red Cells and Platelets in Alzheimer's Disease and Vascular Dementia, Atherosclerosis 65, 237–245.
Montine, T.J., Montine, K.S., and Swift, L.L. (1997) Central Nervous System Lipoproteins in Alzheimer's Disease, Am. J. Pathol. 151, 1571–1575.
Conquer, J.A., Tierney, M.C., Zecevic, J., Bettger, W.J., and Fisher, R.H. (2000) Fatty Acid Analysis of Blood Plasma of Patients with Alzheimer's Disease, Other Types of Dementia, and Cognitive Impairment, Lipids 35, 1305–1312.
Amen, D.G. (2002) Healing ADD: The Breakthrough Program That Allows You to See and Heal the 6 Types of ADD, pp. 67–76, Berkley Publishing Group, New York.
Colquhoun, I., and Bunday, S. (1981) A Lack of Essential Fatty Acids as a Possible Cause of Hyperactivity in Children, Med. Hypotheses 7, 673–679.
Burr, G.O., and Burr, M.M. (1930) On the Nature and Role of the Fatty Acids Essential in Nutrition, J. Biol. Chem. 86, 587–621.
Aman, M.G., Mitchell, E.A., and Turbott, S.H. (1987) The Effects of Essential Fatty Acid Supplementation by Efamol in Hyperactive Children, J. Abnorm. Child Psychol. 15, 75–90.
Richardson, A.J., and Puri, B.K. (2002) A Randomized Double-Blind, Placebo-Controlled Study of the Effects of Supplementation with Highly Unsaturated Fatty Acids on ADHD-Related Symptoms in Children with Specific Learning Difficulties, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26, 233–239.
Elliot, H., and Winston-Salem, N.C. (2002) Attention Deficit Hyperactivity Disorder in Adults: A Guide for the Primary Care Physician, South. Med. J. 95, 736–742.
Le Moal, M., and Simon, H. (1991) Mesocorticolimbic Dopaminergic Networks: Functional and Regulatory Roles, Physiol. Rev. 71, 155–234.
Cook, E.H., Stein, M.A., Krasowski, M.D., Cox, N.J., Olkon, D.M., Kieffer, J.E., and Leventhal, B.L. (1995) Association of Attention-Deficit Disorder and the Dopamine Transporter Gene, Am. J. Hum. Genet. 56, 993–998.
De la Presa Owens, S., and Innis, S.M. (1999) Docosahexaenoic Acid and Arachidonic Acid Prevent a Decrease in Dopaminergic and Serotoninergic Neurotransmitters in Frontal Cortex Caused by a Linoleic and α-Linolenic Acid Deficient Diet in Formula-Fed Piglets, J. Nutr. 129, 2088–2093.
Zimmer, L., Durand, G., Guilloteau, D., and Chalon, S. (1999) n−3 Polyunsaturated Fatty Acid Deficiency and Dopamine Metabolism in the Rat Frontal Cortex, Lipids 34, S251.
Zimmer, L., Delpal, S., Guilloteau, D., Aioun, J., Durand, G., and Chalon, S. (2000) Chronic n−3 Polyunsaturated Fatty Acid Deficiency Alters Dopamine Vesicle Density in the Rat Frontal Cortex, Neurosci. Lett 284, 25–28.
Chalon, S., Delion-Vancassel, S., Belzung, C., Guilloteau, D., Leguisquet, A., Besnard, J.C., and Durand, G., (1998) Dietary Fish Oil Affects Monoaminergic Neurotransmission and Behavior in Rats, J. Nutr. 128, 2512–2519.
Stark, K.D., Mulvad, G., Pedersen, H.S., Park, E.J., Dewailly, E., and Holub, B.J. (2002) Fatty Acid Composition of Serum Phospholipids of Postmenopausal Women: A Comparison Between Greenland Inuit and Canadians Before and After Supplementation with Fish Oil, Nutrition 18, 627–630.
Pelikanova, T., Kazdova, L., Chvojkova, S., and Base, J. (2001) Serum Phospholipids Fatty Acid Composition and Insulin Action in Type 2 Diabetic Patients, Metabolism 50, 1472–1478.
Glatz, J.F., Soffers, A.E., and Katan, M.B. (1989) Fatty Acid Composition of Serum Cholesteryl Esters and Erythrocyte Membranes as Indicators of Linoleic Acid Intake in Man, Am. J. Clin. Nutr. 49, 269–276.
Kohlmeier, L. (1995) Future of Dietary Exposure Assessment, Am. J. Clin. Nutr. 61 (Supp.), 702S-709S.
Arab, L. (2003) Biomarkers of Fat and Fatty Acid Intake, J. Nutr. 133, 925S-932S.
Farquhar, J.W., and Ahrens, E.H. (1963) Effects of Dietary Fats on Human Erythrocyte Fatty Acid Patterns, J. Clin. Invest. 42, 675–685.
Hjartåker, J., Lund, E., and Bjerve, K.S. (1997) Serum Phospholipid Fatty Acid Composition and Habitual Intake of Marine Foods Registered by a Semi-quantitative Food Frequency Questionnaire, Eur. J. Clin. Nutr. 51, 736–742.
Bjerve, K.S., Brubakk, A.M., Fougner, K.J., Johnsen, H., Midthjell, K. and Vik, T. (1993) Omega-3 Fatty Acids: Essential Fatty Acids with Important Biological Effects, and Serum Phospholipid Fatty Acids as Markers of Dietary Omega-3-Fatty Acid Intake, Am. J. Clin. Nutr. 57, 801S-805S.
Godley, P.A., Campbell, M.K., Miller, C., Gallagher, P., Martinson, F.E., Mohler, J.L., and Sandler, R.S. (1996) Correlation Between Biomarkers of Omega-3 Fatty Acid Consumption and Questionnaire Data in African American and Caucasian United States Males With and Without Prostatic Carcinoma, Cancer Epidemiol. Biomarkers Prev. 5, 115–119.
Bekaroglu, M., Aslan, Y., Gedik, Y., Deger, O., Mocan, H., Erduran, E., and Karahan, C. (1996) Relationships Between Serum Free Fatty Acids and Zinc, and Attention Deficit Hyperactivity Disorder: A Research Note, J. Child. Psychol. 37, 225–227.
Cho, H.P., Nakamura, M.T., and Clarke, S.D. (1999) Cloning, Expression, and Nutritional Regulation of the Mammalian Δ-6 Desaturase, J. Biol. Chem. 274, 471–477.
Cho, H.P., Nakamura, M., and Clarke, S.D. (1999) Cloning, Expression, and Fatty Acid Regulation of the Human Δ-5 Desaturase, J. Biol. Chem. 274, 37335–37339.
Bennett, C.N., and Horrobin, D.F. (2000) Gene Targets Related to Phospholipid and Fatty Acid Metabolism in Schizophrenia and Other Psychiatric Disorders: An Update, Prostaglandins Leukotrienes Essent. Fatty Acids 63, 47–59.
MacDonell, L.E., Skinner, F.K., Ward, P.E., Glen, A.I., Glen, A.C., Macdonald, D.J., Boyle, R.M., and Horrobin, D.F. (2000) Increased Levels of Cytosolic Phospholipase A2 in Dyslexics, Prostaglandins Leukotrienes Essent. Fatty Acids. 63, 37–39.
Horrobin, D.F., and Bennett, C.N. (1999) Depression and Bipolar Disorder: Relationships to Impaired Fatty Acid and Phospholipid Metabolism and to Diabetes, Cardiovascular Disease, Immunological Abnormalities, Cancer, Ageing and Osteoporosis: Possible Candidate Genes, Prostaglandins Leukotrienes Essent. Fatty Acids. 60, 217–234.
Gattaz, W.F., Carins, N.J., Levy, R., Forstl, H., Braus, D.F., and Maras, A. (1996) Decreased Phospholipase A2 Activity in the Brain and in Platelets of Patients with Alzheimer's Disease, Eur. Arch. Psychiatry. Clin. Neurosci. 246, 129–131.
Richardson, A.J., and Ross, M.A. (2000) Fatty Acid Metabolism in Neurodevelopmental Disorder: A New Perspective on Associations Between Attention-Deficit/Hyperactivity Disorder, Dyslexia, Dyspraxia and the Autistic Spectrum, Prostaglandins Leukotrienes Essent. Fatty Acids 63, 1–9.
Spencer, T., Biederman, J., Wilens, T., and Faraone, S.V. (1998) Adults with Attention-Deficit/Hyperactivity Disorder: A Controversial Diagnosis, J. Clin. Psychiatry 59 (Suppl. 7), 59–68.
Biederman, J., Faraone, S.V., Spencer, T., Wilens, T., Norman, D., Lapey, K.A., Mick, E., Lehman, B.K., and Doyle, A. (1993) Patterns of Psychiatric Comorbidity, Cognition and Psychosocial Functioning in Adults with Attention Deficit Hyperactivity Disorder, Am. J. Psychiatry 150, 1792–1798.
Bell, J.G., Sargent, J.R., Tocher, D.R., and Dick, J.R. (2000) Red Blood Cell Fatty Acid Composition in a Patient with Autistic Spectrum Disorder: A Characteristic Abnormality in Neurodevelopmental Disorders? Prostaglandins Leukotrienes Essent. Fatty Acids 63, 21–25.
Vancassel, S., Durand, G., Barthelemy, C., Lejeune, B., Martineau, J., Guilloteau, D., Andres, C., and Chalon, S. (2001) Plasma Fatty Acid Levels in Autistic Children, Prostaglandins Leukotrienes Essent. Fatty Acids. 65, 1–7.
Taylor, K.E., Higgins, C.J., Calvin, C.M., Hall, J.A., Easton, T., McDaid, A.M., and Richardson, A.J. (2000) Dyslexia in Adults Is Associated with Clinical Signs of Fatty Acid Deficiency, Prostaglandins Leukotrienes Essent. Fatty Acids 63, 75–78.
Pawlosky, R.J., and Salem, N., Jr. (1999) Alcohol Consumption in Rhesus Monkeys Depletes Tissues of Polyunsaturated Fatty Acids and Alters Essential Fatty Acid Metabolism, Alcohol Clin. Exp. Res. 23, 311–317.
Simon, J.A., Fong, J., Bernert, J.T., and Browner, W.S. (1996) Relation of Smoking and Alcohol Consumption to Serum Fatty Acids, Am. J. Epidemiol. 144, 325–334.
Kuriki, K., Nagaya, T., Tokudome, Y., Imaeda, N., Fujiwara, N., Sata, J., Goto, C., Ikeda, M., Maki, S., Tajima, K., and Tokudome, S. (2003) Plasma Concentrations of (n−3) Highly Unsaturated Fatty Acids Are Good Biomarkers of Relative Dietary Fatty Acids: A Cross-Sectional Study, J. Nutr. 133, 3643–3650.
Fox, H., Ross, B.M., Tocher, D., Horrobin, D., Glen, I., and St. Clair, D. (2003) Degradation of Specific Polyunsaturated Fatty Acids in Red Blood Cells Stored at −20°C Proceeds Faster in Patients with Schizophrenia When Compared to Healthy Controls, Prostaglandins Leukotrienes Essent. Fatty Acids 69, 291–297.
Rinehart, N.J., Bradshaw, J.L., Brereton, A.V., and Tonge, B.J. (2003) A Clinical and Neurobehavioural Review of High-Functioning Autism and Asperger's Disorder, Aust. N.Z. J. Psychiatry 36, 762–770.
Foster, B., and King, B.H. (2003) Asperger Syndrome: To Be or Not to Be? Curr. Opin. Pediatr. 15, 491–494.
Yao, J., Stanley, J.A., Reddy, R.D., Keshavan, M.S., and Pettegrew, J.W. (2002) Correlations Between Peripheral Polyunsaturated Fatty Acid Content and in vivo Membrane Phospholipid Metabolites, Biol. Psychiatry 15, 823–830.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Young, G.S., Maharaj, N.J. & Conquer, J.A. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 39, 117–123 (2004). https://doi.org/10.1007/s11745-004-1209-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-004-1209-3